Outlook
Group Outlook 2024
Fresenius expects general cost inflation to continue at a slightly lower level in the 2024 financial year and the current geopolitical tensions to persist. Fresenius also expects interest rates to remain at a similar level to 2023. Irrespective of this, the Management Board considers the business outlook for the Group to be positive and expects a successful fiscal year 2024.
Fresenius will continue to closely monitor the potential impact of increased volatility and reduced visibility on its business and balance sheet. All of these assumptions are subject to considerable uncertainty.
For 2024, Fresenius expects Group organic revenue growth of 3% to 6%. Group EBIT1,2 is expected to grow in the rage of 4% to 8% (at constant currency).
1 Before special items
2 Base 2023 adjusted
| Fiscal year 2023 (base)2 | Targets 2024 | |
|---|---|---|
Fresenius Group | ||
Revenue growth (organic) | €21,776 m | 3–6% |
EBIT growth1,2 (in constant currency) | €2,220 m | 4–8% |
Operating Companies | ||
Fresenius Kabi | ||
Revenue growth (organic) | €8,009 m | Mid-single-digit percentage growth |
EBIT margin1 | €1,145 m | Around 15% (structural margin band: 14-17%) |
Fresenius Helios | ||
Revenue growth (organic) | €11,952 m | Low-to-mid-single-digit percentage growth |
EBIT margin1 | €1,190 | Within the structural margin band of 9% – 11% |
Investment Company1 | ||
Fresenius Vamed | ||
Revenue growth (organic3) | €2,201 m | Mid-single-digit percentage growth |
EBIT margin1 | -€16 m | 1-2 percentage points below the structural margin band of 4–6% |
-
1 Before special items
2 Base 2023 adjusted
3 Calculated for continued business
As of February 21, 2024
Related Links
Interactive Tool